BRCA1/2 mutations are at the heart of homologous recombination repair deficiency (HRD) in ovarian cancer, and mismatch repair (MMR) detection in ovarian cancer is commonly associated with non-serous ovarian cancer and is often associated with Lynch syndrome. Here, BRCA1 is linked to ovarian carcinoma.